Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001209191-22-014621 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-02 | 2022-02-28 | KPTI | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +63.0K | 63.0K | New | $0 |
| D | 2022-03-02 | 2022-02-28 | KPTI | Mano Michael | SVP, GC, Sec | A - Grant | $0.00 | +81.0K | 81.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | A | A | 63,000 | $0.00 | 63,000 | D | — | — | (F1) Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 28, 2023. |
| 2 | Derivative | Stock Option (right to buy) | 2022-02-28 | A | A | 81,000 | $0.00 | 81,000 | D | $10.33 · — to 2032-02-27 | 81,000 Common Stock | (F2) This option was granted on February 28, 2022 pursuant to the Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter. |